Still curious as to whether a single corporation/person/group/ institution was responsible for last week's volume spike up, since there was no published clinical or transactional news, and there were some fairly large blocks. If one purchaser or associated group acquired more than 5% of the stock, it/she/he/they would have to file SEC form 13-D disclosing that within 10 business days. I am not sure if some one who was already a more than 5% shareholder would have to file that form on acquiring an additional 5% plus. Anybody know?
If some one acquired enough shares to make itself a majority owner,that would seem like a "material event" which would require ENMD itself to report on form 8-K. Anybody know ? Here is a summary of current 8-K filing requirements published as a law firm's PR:
Haod class disclaimer: I know of the firm but have no affiliation with it whatever and do not vouch for anything here.
OT: did I hear on ABC news correctly that there are now concerns expressed about ALEVE ? We've used that stuff quite a bit. Hope I heard wrong.Can aspirin be far behind?
Market Data 
Markets 
AI
